Dra. Teresita Moviglia, médica inmunóloga clínica y directora médica de LYRACELL
Medical and scientific leadership

Dr. Teresita Moviglia

Medical Direction · President of ACIDTA

Clinical immunologist. She leads the scientific backing of the Moviglia Method and presides over ACIDTA, the institution that supports the LYRACELL laboratory.

Clinical immunologyCell therapyTranslational research
Career
+
0
years of research
0
Forbes articles about her research
0
in-house laboratory: LYRACELL Lab
Biography

More than two decades dedicated to regenerative medicine.

Dr. Teresita Moviglia is a physician specializing in clinical immunology. Over more than 20 years of work, she developed the protocol known today as the Moviglia Method: an autologous-based cell therapy approach that combines mesenchymal stem cells with tissue-specific lymphocytes.

She presides over ACIDTA (Asociación Civil para la Investigación y Desarrollo de Terapias Avanzadas, a civil association for research and development in advanced therapies), the scientific institution that supports LYRACELL Lab, LYRACELL’s in-house laboratory.

Scientific recognition

Research with international impact.

Science Advances · 2023She is co-author of the study “The synovial environment steers cartilage deterioration and regeneration” (Bolander, J., Moviglia, M.T. et al.), published together with Wake Forest School of Medicine.

ForbesScientist and columnist William A. Haseltine —a Harvard Medical School graduate— devoted two articles to this research, describing it as a significant advance in research on the treatment of osteoarthritis.

View the full research →

Your next step

Request a medical evaluation.

The LYRACELL medical team defines the most suitable approach based on your diagnosis.